Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF45 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RBBP6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DHX8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF678 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RP11-111H13.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CRAMP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CR392000.1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | LIG4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF562 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PLPPR2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |